Related Experiment Videos
T- and B-cell responses in patients with malignant pleural effusions
British Journal of Cancer
|April 1, 1981
Summary
Cancer patients with malignant pleural effusions show higher immunoglobulin levels within the effusion but lower serum immunoglobulin levels compared to non-cancer patients. Lymphocyte proliferation differs significantly between cancer and non-cancer effusions.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Pleural effusions are fluid accumulations in the thoracic cavity, often associated with various conditions including cancer.
- Understanding the immunological characteristics of lymphocytes within pleural effusions is crucial for diagnosing and managing diseases.
Purpose of the Study:
- To compare immunological and cellular features of lymphocytes in pleural effusions and blood from cancer patients, benign effusions, and healthy donors.
- To investigate differences in immunoglobulin and total protein levels in effusions and serum.
- To assess lymphocyte proliferation and T-cell/B-cell content.
Main Methods:
- Analysis of cytological features, rosette-forming capacity, immunofluorescent staining, and PHA-stimulated DNA synthesis in lymphocytes.
- Quantification of total protein and immunoglobulin (IgG, IgA, IgM) levels in pleural effusions and serum.
- Comparison between metastatic effusions, non-metastatic effusions, and blood samples.
Main Results:
- Metastatic effusions had significantly higher immunoglobulin and total protein content than non-metastatic effusions.
- Serum immunoglobulin levels were higher in non-cancer patients compared to cancer patients.
- No significant difference in relative T- or B-cell content, but increased spontaneous lymphocyte proliferation in cancer effusions.
- Lower PHA-stimulated transformation index in cancer patient effusions.
Conclusions:
- Pleural effusions in cancer patients exhibit distinct immunological profiles, including elevated immunoglobulins and altered lymphocyte proliferation.
- Serum immunoglobulin levels may serve as a differentiating marker between cancer and non-cancer patients.
- The findings suggest impaired lymphocyte responsiveness in the pleural environment of cancer patients.